← Back to Search

Episiotomy Scar Massage for Postpartum Pelvic Health (EPIS Trial)

N/A
Recruiting
Led By Erin Brennand, MD, MSc
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
6-10 weeks postpartum after vaginal delivery with episiotomy
Age ≥18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if teaching new mothers to massage their childbirth scars can improve their pelvic health. The study will involve women who have given birth and have healed scars. The massage is expected to make the scar tissue more flexible and reduce discomfort.

Who is the study for?
This trial is for first-time mothers over 18, within 6-10 weeks postpartum after a vaginal delivery with episiotomy. They must have healed scars as confirmed by their doctor and be able to understand English well enough to follow an instructional video and fill out questionnaires.
What is being tested?
The study tests if self-scar tissue massage on the perineal area can improve pelvic health in new moms. Participants will either perform self-massage following an instructional video or receive routine care without massage, to compare outcomes using pelvic health questionnaires.
What are the potential side effects?
Since this intervention involves non-invasive self-massage, side effects are expected to be minimal but may include discomfort or pain at the scar site during or after performing the massage.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 6-10 weeks postpartum after a vaginal delivery with an episiotomy.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of Pelvic Floor Distress Inventory (PFDI-20) Outcome Measures with missing data
Number of The Carol Scale with missing data
Number of participants to complete self-scar massage protocol as intended
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Episiotomy and Vaginal/Perineal Tear Self-Scar MassageExperimental Treatment1 Intervention
This Arm will be instructed in and perform self-scar massage to their pelvic floor scar tissue.
Group II: Standard Postnatal CareActive Control1 Intervention
This Arm will not be instructed in or perform self-scar massage to their pelvic floor scar tissue.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for perineal tears, particularly those involving physical manipulation and massage of scar tissue, aim to improve tissue flexibility, reduce pain, and enhance pelvic function. These treatments work by breaking down adhesions and scar tissue, promoting better blood flow, and encouraging the realignment of collagen fibers within the scar. This can lead to increased elasticity and reduced discomfort in the affected area. For patients with perineal tears, these benefits are crucial as they can significantly improve postpartum recovery, alleviate pain during activities such as sitting or intercourse, and enhance overall pelvic health.

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
811 Previous Clinical Trials
889,446 Total Patients Enrolled
Alberta Health servicesOTHER
163 Previous Clinical Trials
652,528 Total Patients Enrolled
Alberta Innovates Health SolutionsOTHER
53 Previous Clinical Trials
94,013 Total Patients Enrolled
Erin Brennand, MD, MScPrincipal InvestigatorUniversity of Calgary

Media Library

Episiotomy Scar Tissue Self-Scar Massage Clinical Trial Eligibility Overview. Trial Name: NCT05908292 — N/A
Perineal Tears Research Study Groups: Episiotomy and Vaginal/Perineal Tear Self-Scar Massage, Standard Postnatal Care
Perineal Tears Clinical Trial 2023: Episiotomy Scar Tissue Self-Scar Massage Highlights & Side Effects. Trial Name: NCT05908292 — N/A
Episiotomy Scar Tissue Self-Scar Massage 2023 Treatment Timeline for Medical Study. Trial Name: NCT05908292 — N/A
~58 spots leftby Dec 2025